Skip to main content
. 2022 Jul 23;135(12):1404–1413. doi: 10.1097/CM9.0000000000002217

Figure 1.

Figure 1

Flowchart describing the selection of advanced non-small cell lung cancer patients treated with first-line single-agent immune checkpoint inhibitors.